Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?

Lower dosing of enteric-coated mycophenolate sodium (Myfortic) can achieve target mycophenolic acid exposure rapidly in most Chinese renal transplant patients: a pilot study

(2014) H. Yin et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Evaluation of Mycophenolic Acid Exposure Using a Limited Sampling Strategy in Renal Transplant Recipients

(2013) Jun Li et al.   AMERICAN JOURNAL OF NEPHROLOGY

Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review

(2013) J.C. Stingl et al.   PHARMACOLOGY & THERAPEUTICS

Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen

(2012) E. D. Greanya et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers

(2012) Dong Guo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Genotype and allele frequencies of polymorphic UGT1A9 in the Polish population

(2012) Oliwia Zakerska et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Race and Drug Formulation Influence on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Recipients

(2012) Kathleen M. Tornatore et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals

(2011) Geng Fang et al.   CLINICA CHIMICA ACTA

Mycophenolic Acid Pharmacokinetics During Maintenance Immunosuppression in African American and Caucasian Renal Transplant Recipients

(2011) Kathleen M. Tornatore et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipients

(2011) Rachida Bouamar et al.   Pharmacogenetics and Genomics

The CLEAR Study: A 5-day, 3-g Loading Dose of Mycophenolate Mofetil versus Standard 2-g Dosing in Renal Transplantation

(2010) S. Gourishankar et al.   Clinical Journal of the American Society of Nephrology

A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits

(2010) I. Etienne et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

SLCO1B1genetic polymorphism influences mycophenolic acid tolerance in renal transplant recipients

(2010) Hugues Michelon et al.   PHARMACOGENOMICS

Pharmacogenetic influences on mycophenolate therapy

(2010) Katherine A Barraclough et al.   PHARMACOGENOMICS

Population Pharmacokinetics Analysis of Mycophenolic Acid in Adult Kidney Transplant Patients With Chronic Graft Dysfunction

(2010) Benjamin A Guillet et al.   THERAPEUTIC DRUG MONITORING

Development and Validation of Limited Sampling Strategies for Tacrolimus and Mycophenolate in Steroid-Free Renal Transplant Regimens

(2010) Eric Poulin et al.   THERAPEUTIC DRUG MONITORING

Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients

(2009) Dirk R. Kuypers et al.   CLINICAL PHARMACOKINETICS

The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics

(2009) N Picard et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

UGT1A9 -275T>A/-2152C>T Polymorphisms Correlate With Low MPA Exposure and Acute Rejection in MMF/Tacrolimus-Treated Kidney Transplant Patients

(2009) R H N van Schaik et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Longitudinal evaluation of mycophenolic acid pharmacokinetics in pediatric kidney transplant recipients. The role of post-transplant clinical and therapeutic variables

(2009) Luciana Ghio et al.   CLINICAL TRANSPLANTATION

African American Kidney Transplantation Survival

(2009) Gregory E. Malat et al.   DRUGS

No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation

(2009) Masatomo Miura et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation

(2009) Hylke de Jonge et al.   THERAPEUTIC DRUG MONITORING

Early Phase Limited Sampling Strategy Characterizing Tacrolimus and Mycophenolic Acid Pharmacokinetics Adapted to the Maintenance Phase of Renal Transplant Patients

(2009) Masatomo Miura et al.   THERAPEUTIC DRUG MONITORING

Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9

(2008) Zheng Jiao et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients

(2008) Dirk R.J. Kuypers et al.   CLINICAL THERAPEUTICS

Influence of Drug Transporters and UGT Polymorphisms on Pharmacokinetics of Phenolic glucuronide Metabolite of Mycophenolic Acid in Japanese Renal Transplant Recipients

(2008) Masatomo Miura et al.   THERAPEUTIC DRUG MONITORING

Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial

(2008) Teun van Gelder et al.   TRANSPLANTATION

Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients

(2008) W.-X. Zhang et al.   XENOBIOTICA